Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
FDA’s New Orphan Products Director Brings Industry, Legal, Academic, Regulatory Background
Aug 02 2021
•
By
Derrick Gingery
The FDA has a new director of the Office of Orphan Products Development. • Source: Alamy
More from Agency Leadership
More from Pink Sheet